IBRX
Immunitybio Inc
Price:  
2.71 
USD
Volume:  
9,066,208.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IBRX WACC - Weighted Average Cost of Capital

The WACC of Immunitybio Inc (IBRX) is 7.9%.

The Cost of Equity of Immunitybio Inc (IBRX) is 8.20%.
The Cost of Debt of Immunitybio Inc (IBRX) is 7.15%.

Range Selected
Cost of equity 7.10% - 9.30% 8.20%
Tax rate -% - -% -%
Cost of debt 7.00% - 7.30% 7.15%
WACC 7.1% - 8.8% 7.9%
WACC

IBRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.7 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 9.30%
Tax rate -% -%
Debt/Equity ratio 0.31 0.31
Cost of debt 7.00% 7.30%
After-tax WACC 7.1% 8.8%
Selected WACC 7.9%